EyePoint Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
EyePoint Pharmaceuticals 根據納斯達克上市規則5635(C)(4)報告誘導授予。
EyePoint Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
EyePoint Pharmaceuticals 根據納斯達克上市規則5635(C)(4)報告誘導授予。
使用瀏覽器的分享功能,分享給你的好友吧